Regen BioPharma develops new approach for boosting CAR-T cell efficiency to treat solid tumors

Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies

Sponsored by 10 Mar 2022

Combination Therapies: Opportunities for Improved CAR-T Cell Therapy?

In Depth 11 Oct 2021

A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology

ADVERTISEMENT

Microbiome Medicines Could Power Up CAR-T Cell Therapies

Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas

Autolus Reveals Early Clinical Data of Next-Gen CAR-T Therapy

First Results Out for Off-the-Shelf CAR-T Therapy in Solid Tumors

Manufacturing Delays Set Back Autolus’ CAR-T Programs by Five Months

Interview 28 May 2019

Getting Ahead of the Pack in the CAR-T Field

Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma

UK Biotech Gets Huge Grant to Launch Off-the-Shelf CAR-T Cancer Therapy to Clinic